Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/onemedpl/public_html/database/comp_profile_include.php on line 64
Biotech Specialty Pharma

Quantum Immunologics, Inc.

2202 N. West Shore Blvd., Suite 200
Tampa, FL 33623 USA

Warning: Use of undefined constant php - assumed 'php' (this will throw an Error in a future version of PHP) in /home/onemedpl/public_html/database/comp_profile_include.php on line 92
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Products for the treatment of breast cancer and studies in other types of cancer.

Management Charles Broes, CEO; Josh Coughlin, Chief Investment Officer; Timothy Schwiers, Investor Relations; Kent J. Johnson, MD, Chief Scientific Advisor; Martin P. Eason, MD, JD, Chief of Industry Relations and Director; Barry D. Rooth, JD, Chief of Corporate Affairs and Director; Don Wright, MBA, CMA, Chief Financial Officer; Taina S. Broes, Chief Operating Officer; Eric W. Olle, PhD., Director of Research Bernie D. Bicoy, Director

Click here for Financial Data
Keywords: cancer, immunotherapy, cancer screening, cancer monitoring, vaccine, Cancer-immunotherapy, cancer-vaccine, breast-cancer, cancer-diagnostics, cancer-treatment


Updated: Sept. 21, 2012


Quantum Immunologics (QI) is a privately held company that is dedicated to improving the treatment outcome and quality of life for cancer patients through the research, development, and production of ......view more

Products / Services

Individualized Cancer Immunotherapy System The vaccine is individually prepared for women already diagnosed with breast cancer. Blood drawn from a patient is treated with our patented process, and th......view more

Technology / Differentiation

Quantum's approach to cancer immunotherapy involves sensitizing the dendritic cells from a patient's own blood to recognize and direct the body's immune system to attack breast cancer sites in a targe...view more

Revenue / Funding

$9 million raised from 440 investors over the years. one class of common stock. once this prelimary data in 45 days. for our next clinical trial IIb, probably need another $12 million....view more

...view more


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in /home/onemedpl/public_html/include/counter.php:10 Stack trace: #0 /home/onemedpl/public_html/database/comp_profile_include.php(1079): include() #1 /home/onemedpl/public_html/database/comp_profile.php(87): include('/home/onemedpl/...') #2 {main} thrown in /home/onemedpl/public_html/include/counter.php on line 10